nanoComposix
nanoComposix is a San Diego-based nanotechnology company, founded in 2004 and now part of Fortis Life Sciences, that manufactures engineered gold, silver, silica, magnetic, and platinum nanoparticles for pharmaceutical, diagnostic, and life sciences customers through catalog sales and custom GMP CDMO services.
- Company typePrivate
- Founded2004
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What nanoComposix does
nanoComposix is a San Diego-based nanotechnology company, founded in 2004, that designs, manufactures, and commercializes engineered inorganic nanoparticles — including gold, silver, silica, magnetic, and platinum compositions — for pharmaceutical, diagnostic, life sciences, and adjacent industrial customers. Its core capability is proprietary colloidal synthesis combined with tangential flow filtration purification, allowing reproducible batch production ranging from research-scale to 2,000 liters at 1 OD and 100 liters at 20 OD, with 37 GMP batches produced and 20 preclinical programs supported to date. The platform has been cited in 4,000+ peer-reviewed publications, indicating broad embedding in third-party research and a meaningful installed base among academic and industrial users.
The business operates a dual model. The first leg is a catalog of off-the-shelf nanoparticles and application-ready diagnostic reagents, including the BioReady line and the AmpliDetect multiplex nucleic acid lateral flow platform, distributed through five regional partners covering North America, the UK, Europe, Japan, and Germany/Austria. The second leg is fee-for-service custom synthesis and CDMO work for nanomedicine, with custom projects starting in the low thousands of dollars and scaling into GMP manufacturing agreements. Quality systems are anchored by ISO 13485:2016 certification, FDA drug establishment registration, and a California Drug Manufacturing License.
In July 2021, nanoComposix was acquired by Fortis Life Sciences, placing it inside a roll-up platform in life sciences tools and CDMO services. Headcount sits in the 11–50 range. The company now participates across diverse verticals including pharma, diagnostics, animal health, energy, engineering, and dermatology, reducing dependence on any single end-market.
nanoComposix firmographics
Firmographics- Name
- nanoComposix
- Legal name
- nanoComposix, Inc.
- Website
- https://nanocomposix.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- nanoComposix is a San Diego-based nanotechnology company, founded in 2004 and now part of Fortis Life Sciences, that manufactures engineered gold, silver, silica, magnetic, and platinum nanoparticles for pharmaceutical, diagnostic, and life sciences customers through catalog sales and custom GMP CDMO services.
- Ownership category
- akta.pro rank
nanoComposix industry classification
Industry- Product category
- Engineered Nanomaterials
- NAICS
- Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where nanoComposix is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
nanoComposix business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Catalog Nanoparticle Products: Sale of standardized nanoparticle products across gold, silver, silica, magnetic, platinum, and other materials. Products are sold at various price points based on material, size, surface chemistry, and concentration. Revenue is transactional, one-time per order.
- Bulk Manufacturing: High-volume nanoparticle manufacturing with tiered bulk discounts for customers requiring larger quantities (hundreds of milliliters to hundreds of liters) for commercial applications such as lateral flow assays, coatings, and sensors.
- CDMO Services: Contract development and manufacturing organization services for nanomedicine development including feasibility studies, pre-clinical development, GMP manufacturing, and regulatory support. Revenue generated through project-based service contracts and milestone payments.
- Custom Nanoparticle Development: Custom synthesis and development services organized in tiered packages (NanoFab Mini, QuickStart, Pro) to support feasibility studies, optimization, and scale-up assessment. Customers pay for defined development scopes.
- Characterization Services: Analytical testing services including DLS, ICP-MS, TEM, SEM, UV-Vis, zeta potential, and endotoxin testing offered as standalone services to support customer R&D and quality control needs.
- Custom Conjugation Services: Custom conjugate development and manufacturing services transforming nanoparticles into application-ready reagents through antibody functionalization, process optimization, and scalable manufacturing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Gold Nanoparticle Pricing (catalog, small volume) |
| Unit Pricing | Pay-as-you-go | Silver Nanoparticle Pricing (catalog, small volume) |
| Unit Pricing | Pay-as-you-go | Silica Nanoparticle Pricing (catalog) |
| Unit Pricing | Pay-as-you-go | BioReady Diagnostic Products |
| Unit Pricing | Pay-as-you-go | Hydroxyapatite Nanoparticles |
| Unit Pricing | Pay-as-you-go | Titania Nanoparticles |
| Other | Multi-year contract | Custom Development Packages |
| Other | Multi-year contract | Nanomedicine CDMO Services |
| Unit Pricing | Pay-as-you-go | Characterization Services |
| Unit Pricing | Multi-year contract | Bulk Nanoparticle Pricing (tiered) |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels9 records
nanoComposix product offering
Product offeringCore offering
nanoComposix designs, manufactures, and sells precisely engineered nanoparticles — including gold, silver, silica, magnetic iron oxide, platinum, aluminum, hydroxyapatite, titania, and PLGA polymer particles — produced via proprietary colloidal synthesis methods with tight size and shape distributions and a broad surface chemistry platform. The company complements its catalog nanoparticle business with custom synthesis (NanoFab packages), custom conjugation services, contract CDMO services for nanomedicine from feasibility through GMP clinical manufacturing, bulk manufacturing, and analytical characterization services. These products and services support diagnostics developers, pharmaceutical/biotech researchers, optical engineering teams, dermatology and aesthetics customers, and life science researchers.
Product overview
nanoComposix is a nanomaterials company that offers a comprehensive portfolio of precisely engineered nanoparticles and contract development manufacturing services. The core product lines include gold nanoparticles (NanoXact, BioReady, Ultra Uniform sub-brands), silver nanoparticles, silica nanoparticles, magnetic iron oxide particles, platinum nanoparticles, and custom nanomaterials (aluminum, hydroxyapatite, titania, PLGA polymers). These are complemented by BioReady diagnostics reagents including conjugation kits and AmpliDetect multiplex detection products. The company provides services including custom nanoparticle development (NanoFab packages), custom conjugation services, Nanomedicine CDMO services, bulk manufacturing, and characterization services. Supporting tools include Mie Theory, conversion, and molecular weight calculators plus an LFA particle selection guide. The portfolio is delivered as a unified offering combining catalog products with development services, enabling customers to progress from research through clinical manufacturing.
Differentiator
Problem solved
Functional benefit
Brands
- BioReady: Product line of nanoparticles optimized for diagnostic assay development, including gold nanoparticles and magnetic beads with conjugation-ready surfaces.
- NanoXact
- BioPure
- Ultra Uniform
- NanoFab
Products and services
- Gold Nanoparticles (NanoXact / BioReady / Ultra Uniform)
Quantifiable outcome
- 40 nm streptavidin gold conjugate produces less than 20% signal compared to nanoComposix conjugate at 1 nM analyte concentration in lateral flow comparison testing
- +2 more outcomes
Companies that use nanoComposix
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles5 records
nanoComposix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
nanoComposix partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered primary and secondary.
- BIOZOL Diagnostica Vertrieb GmbHprimaryDistribution agreement signed to broaden distribution of nanoComposix products to customers throughout Germany and Austria. nanoComposix products made available through BIOZOL's established distribution network in these markets.
- University of MinnesotasecondaryJoint webinar collaboration featuring Dr. Bischof and Dr. Kholsa from University of Minnesota discussing advancement in nanowarming and impact on critical animal models for drug therapies and genetic studies.
- FluroTech Ltd.secondaryJoint venture announced for SARS-CoV2 test method optimization. nanoComposix began optimization work on FluroTech's rapid SARS-CoV2 testing technology combining nanoComposix nanoparticle expertise with FluroTech's testing platform.
- Therma Bright Inc.secondaryEngagement with Therma Bright and Orpheus Medica to accelerate development of CoviSafe rapid saliva test following successful completion of feasibility studies.
- EM JapanprimaryDistribution agreement signed to broaden distribution of nanoComposix products to customers throughout Japan.
- VeritasprimaryPartnership established to improve access for customers in Japan to nanoComposix nanoparticle products and technologies.
- CliniSciencesprimaryPartnership established for expanding distribution of nanoComposix materials and technologies to customers throughout Europe.
- Stratech Scientific Ltd.primaryDistribution agreement signed for distribution of nanoComposix products in the United Kingdom market.
- EnduRx Pharmaceuticals Inc.secondaryCollaboration on nanoparticle formulation development partnership. Customer reported positive experience with nanoComposix scientists working alongside their team to hone early stage product design.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
nanoComposix competitors and assessment
Company assessmentDirect peers
- BBI Solutions: BBI Solutions (now part of Sona Nanotech) supplies colloidal gold nanoparticles and conjugation services for diagnostic test manufacturers globally, overlapping nanoComposix's BioReady reagent and lateral-flow assay focus.
- Nanopartz: Nanopartz manufactures precisely engineered gold and silver nanoparticles with tight size distributions for research, diagnostics, and therapeutic applications — directly overlapping nanoComposix's NanoXact and BioReady product portfolios.
- Creative Diagnostics: Creative Diagnostics offers gold nanoparticle conjugates, lateral-flow components, and diagnostic reagent kits for immunoassay developers, with overlapping product offerings in the diagnostics segment.
- Ted Pella: Ted Pella manufactures and distributes nanoparticle products and supplies for electron microscopy and life-science research, with gold nanoparticle offerings that overlap nanoComposix's NanoXact catalog.
- Nanocs: Nanocs produces functionalized gold, silver, and magnetic nanoparticles plus diagnostic-grade reagents, serving life-science and diagnostic customers in a comparable catalog-plus-custom model.
- Cytodiagnostics: Cytodiagnostics offers gold nanoparticle conjugates, conjugation kits, and lateral-flow reagents for diagnostics and biosensors — directly comparable to nanoComposix's BioReady diagnostic reagent line.
- Lubrizol Life Science (Particle Sciences): Particle Sciences, part of Lubrizol Life Science, is a CDMO specializing in particle-based drug delivery including nanoparticles, PLGA microparticles, and complex formulations — closely matching nanoComposix's nanomedicine CDMO service line.
Broad incumbents
- Catalent: Catalent is a top-tier global CDMO with broad drug-product and biologics manufacturing services including biologic and cell-therapy capabilities adjacent to nanomedicine, competing with nanoComposix for outsourced pharmaceutical manufacturing budgets.
- MilliporeSigma (Sigma-Aldrich): MilliporeSigma distributes catalog gold, silver, magnetic, and other nanoparticles through a global life-science catalog with very different scale, overlapping nanoComposix's catalog offerings as a much larger incumbent.
Others
- Fortis Life Sciences: Fortis Life Sciences is nanoComposix's parent company (acquired July 2021) and a broader life-sciences platform providing strategic backing, complementary portfolio assets, and cross-portfolio commercial leverage rather than competing directly.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
nanoComposix social profiles
Digital presencenanoComposix compliance and trust
Trust signalCompliance3 records
nanoComposix financial estimates
Financial estimateRevenue estimate
Valuation estimate
nanoComposix leadership team
Management profileNumber of profiles
Profiles1 record
nanoComposix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
nanoComposix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about nanoComposix
What does nanoComposix do?
nanoComposix designs, manufactures, and sells precisely engineered nanoparticles — including gold, silver, silica, magnetic iron oxide, platinum, aluminum, hydroxyapatite, titania, and PLGA polymer particles — produced via proprietary colloidal synthesis methods with tight size and shape distributions and a broad surface chemistry platform. The company complements its catalog nanoparticle business with custom synthesis (NanoFab packages), custom conjugation services, contract CDMO services for nanomedicine from feasibility through GMP clinical manufacturing, bulk manufacturing, and analytical characterization services. These products and services support diagnostics developers, pharmaceutical/biotech researchers, optical engineering teams, dermatology and aesthetics customers, and life science researchers.
Is nanoComposix a public or private company?
nanoComposix is a private company. It is classified as corporate owned and is currently operating.
When was nanoComposix founded?
nanoComposix was founded in 2004. It employs 11 to 50 people.
Where is nanoComposix based?
nanoComposix is headquartered in San Diego, United States, in the North America region.
How does nanoComposix make money?
Six revenue lines are on record. Catalog Nanoparticle Products are the primary driver. The others are bulk Manufacturing, CDMO Services, custom Nanoparticle Development, characterization Services and custom Conjugation Services.
Who are nanoComposix's main competitors?
Direct peers on record are BBI Solutions, Nanopartz, Creative Diagnostics, Ted Pella, Nanocs, Cytodiagnostics and Lubrizol Life Science (Particle Sciences). Broad incumbents are Catalent and MilliporeSigma (Sigma-Aldrich). Fortis Life Sciences is listed as an others.
Does nanoComposix have an API?
No public API is recorded for nanoComposix.
What industry is nanoComposix in?
nanoComposix's product category is Engineered Nanomaterials. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 541713 and its SIC code is 8731.